216 related articles for article (PubMed ID: 20815304)
1. Sublingual immunotherapy in polysensitized patients: effect on quality of life.
Ciprandi G; Cadario G; Valle C; Ridolo E; Verini M; Di Gioacchino M; Minelli M; Gangemi S; Sillano V; Colangelo C; Pravettoni V; Pellegrino R; Borrelli P; Fiorina A; Carosso A; Gasparini A; Riario-Sforza GG; Incorvaia C; Puccinelli P; Scurati S; Frati F
J Investig Allergol Clin Immunol; 2010; 20(4):274-9. PubMed ID: 20815304
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
Giordano T; Quarta C; Bruno ME; Falagiani P; Riva G
Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
[TBL] [Abstract][Full Text] [Related]
4. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
5. The POLISMAIL lesson: sublingual immunotherapy may be prescribed also in polysensitized patients.
Ciprandi G; Incorvaia C; Puccinelli P; Scurati S; Masieri S; Frati F
Int J Immunopathol Pharmacol; 2010; 23(2):637-40. PubMed ID: 20646360
[TBL] [Abstract][Full Text] [Related]
6. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy in children with allergic polysensitization.
Ciprandi G; Cadario G; Di Gioacchino GM; Gangemi S; Gasparini A; Isola S; Marengo F; Minelli S; Ricciardi L; Ridolo E; Pravettoni V; Valle C; Verini M; Zambito M; Incorvaia C; Puccinelli P; Scurati S; Frati F; Simonetta M
Allergy Asthma Proc; 2010; 31(3):227-31. PubMed ID: 20615323
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of sublingual immunotherapy in Asian children.
Park IH; Hong SM; Lee HM
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
10. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sublingual specific immunotherapy on allergic asthma and rhinitis in children's real life.
De Castro G; Zicari AM; Indinnimeo L; Tancredi G; di Coste A; Occasi F; Castagna G; Giancane G; Duse M
Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2225-31. PubMed ID: 23893190
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results.
Kim ST; Han DH; Moon IJ; Lee CH; Min YG; Rhee CS
Am J Rhinol Allergy; 2010; 24(4):271-5. PubMed ID: 20819465
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
[TBL] [Abstract][Full Text] [Related]
14. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
Wolthers OD; Høst A; Frederiksen B; Halken S
Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
[TBL] [Abstract][Full Text] [Related]
15. Clinical bystander effect exerted by allergen immunotherapy: a hypothesis.
Ciprandi G
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):62-3. PubMed ID: 25781197
[TBL] [Abstract][Full Text] [Related]
16. Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life.
Novakova SM; Staevska MT; Novakova PI; Yoncheva MD; Bratoycheva MS; Musurlieva NM; Tzekov VD; Nicolov DG
Health Qual Life Outcomes; 2017 Sep; 15(1):189. PubMed ID: 28962623
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
Riechelmann H; Schmutzhard J; van der Werf JF; Distler A; Kleinjans HA
Am J Rhinol Allergy; 2010; 24(5):e104-9. PubMed ID: 21244725
[TBL] [Abstract][Full Text] [Related]
18. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
Du X; Shu C; Xu G; Ma M; Song H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
Wise SK; Schlosser RJ
Otolaryngol Clin North Am; 2012 Oct; 45(5):1045-54. PubMed ID: 22980684
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of allergic rhinitis caused by grass pollen or house-dust mites in Spain.
Valero A; Justicia JL; Antón E; Dordal T; Fernández-Parra B; Lluch M; Montoro J; Navarro AM
Am J Rhinol Allergy; 2011; 25(4):e123-8. PubMed ID: 21310119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]